PNP Knockout HAP1 Cell Line

The choice depends on whether you are studying PNP (purine nucleoside phosphorylase)'s role in purine salvage or modeling severe combined immunodeficiency (SCID) caused by PNP deficiency. The Knockout line is the standard tool for asking whether PNP is required for cellular purine handling — PNP catalyzes the phosphorolytic cleavage of inosine, guanosine, deoxyinosine, and deoxyguanosine to their respective bases and (deoxy)ribose-1-phosphate. Overexpression is useful for testing PNP-targeted prodrug activation strategies. For purine metabolism research, the EDITGENE PNP Knockout in HAP1 enables study of purine salvage. PNP deficiency causes T-cell immunodeficiency (SCID with selective T-cell defect) through accumulation of toxic deoxyguanosine in lymphocytes. Rescue with wild-type or patient-derived mutant PNP enables disease genotype-function studies. The knockout is also a critical specificity control for PNP inhibitors (forodesine/immucillin-H, ulodesine) — these compounds are being studied for T-cell lymphoproliferative disorders and gout.

Primary applications: • Purine nucleoside levels: intracellular inosine, guanosine, deoxyinosine, deoxyguanosine LC-MS analysis to characterize PNP loss-induced purine accumulation. • dGTP toxicity: studies of deoxyguanosine-induced cellular toxicity given dGTP accumulation in PNP-deficient cells. • PNP-SCID modeling: rescue with patient-derived mutant PNP enables genotype-function correlation studies of immunodeficiency. • PNP inhibitor specificity: critical genetic control for forodesine (immucillin-H) and ulodesine in T-cell lymphoproliferative disorder and gout drug development. EDITGENE recommends this model for researchers investigating purine metabolism, PNP-deficient immunodeficiency, and PNP-targeted drug development.

Yes. PNP rescue experiments are well-established for purine metabolism research: • Construct design: use a codon-modified PNP sequence with a small C-terminal tag (FLAG, HA). PNP is a cytoplasmic homotrimer — preserve trimerization regions. • Catalytically-dead rescue: active site mutations (e.g., conserved residues in the phosphate-binding pocket) abolish enzymatic activity and serve as the standard specificity control. • SCID mutation rescue: patient-derived PNP mutations enable disease genotype-function studies. • Functional readout: rescue should restore inosine/guanosine clearance measured by LC-MS metabolomic profiling. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.